Sign in

CIK 0001756262

  • Large accelerated filer

TransMedics Group, Inc.

Sign in to watch
Ticker
TMDX
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
MA
Entity type
Operating
Phone
+1 978-552-0900
Business address
200 MINUTEMAN ROAD, ANDOVER, MA, 01810
Open-market buys, last 90 days
$109,058
in 1 filing
Open-market sales, last 90 days
$385,464
in 1 filing

Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. TOBIN JAMES R −$385K Director sold 58% of stake
  2. Weill David +$109K Director 1 filing

Reading 31 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-05 Khayal Tamer I Chief Commercial Officer Exercise or conversion +14,548 $0.39 $6K 60,624
2021-03-05 Khayal Tamer I Chief Commercial Officer Exercise or conversion +5,452 $0.28 $2K 66,076
2021-03-05 Khayal Tamer I Chief Commercial Officer Sale −5,783 $30.45 $176K 60,293
2021-03-05 Khayal Tamer I Chief Commercial Officer Sale −14,217 $31.09 $442K 46,076
2021-03-05 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) −14,548 0
2021-03-05 Khayal Tamer I Chief Commercial Officer Exercise or conversion · Stock Option (Right to Buy) −5,452 52,177
2021-02-24 Gordon Stephen Chief Financial Officer Grant or award · Stock Option (Right to Buy) +70,000 70,000
2021-02-24 Hassanein Waleed H President & CEO Grant or award · Stock Option (Right to Buy) +310,000 310,000
2021-02-24 Carey John F VP of Operations Grant or award · Stock Option (Right to Buy) +25,000 25,000
2021-02-24 Sullivan John F VP of Quality & Engineering Grant or award · Stock Option (Right to Buy) +25,000 25,000
2021-02-24 Khayal Tamer I Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +70,000 70,000
2021-02-24 Provost Miriam VP of US Regulatory & FDA Rel. Grant or award · Stock Option (Right to Buy) +25,000 25,000
2021-02-24 DAMME LAURA VP, Clinical Affairs Grant or award · Stock Option (Right to Buy) +25,000 25,000
2021-02-16 Gordon Stephen Chief Financial Officer Exercise or conversion +10,000 $0.67 $7K 10,000
2021-02-16 Gordon Stephen Chief Financial Officer Sale −10,000 $31.33 $313K 0
2021-02-16 Gordon Stephen Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 45,713
2021-02-09 Sullivan John F VP of Quality & Engineering Exercise or conversion +8,600 $0.28 $2K 19,428
2021-02-09 Sullivan John F VP of Quality & Engineering Sale −8,400 $32.78 $275K 11,028
2021-02-09 Sullivan John F VP of Quality & Engineering Sale −200 $34.18 $7K 10,828
2021-02-09 Sullivan John F VP of Quality & Engineering Exercise or conversion · Stock Option (Right to Buy) +8,600 0

Page 46 of 49 · 980 trades